{"organizations": [], "uuid": "087922c5c03794e03bc172658a4d0cd7aff5aa14", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-mylan-expands-access-to-hiv-aids-m/brief-mylan-expands-access-to-hiv-aids-medicines-with-launch-of-first-generic-sustiva-tablets-idUSASB0C3HS", "country": "US", "domain_rank": 408, "title": "BRIEF-Mylan Expands Access To HIV/AIDS Medicines With Launch Of First Generic Sustiva Tablets", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-01T14:35:00.000+02:00", "replies_count": 0, "uuid": "087922c5c03794e03bc172658a4d0cd7aff5aa14"}, "author": "", "url": "https://www.reuters.com/article/brief-mylan-expands-access-to-hiv-aids-m/brief-mylan-expands-access-to-hiv-aids-medicines-with-launch-of-first-generic-sustiva-tablets-idUSASB0C3HS", "ord_in_thread": 0, "title": "BRIEF-Mylan Expands Access To HIV/AIDS Medicines With Launch Of First Generic Sustiva Tablets", "locations": [], "entities": {"persons": [{"name": "lau", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "mylan nv - co", "sentiment": "none"}, {"name": "first generic sustiva tablets reuters staff  feb", "sentiment": "none"}, {"name": "mylan nv", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "mylan", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 1, 2018 / 12:35 PM / in 6 minutes BRIEF-Mylan Expands Access To HIV/AIDS Medicines With Launch Of First Generic Sustiva Tablets Reuters Staff \nFeb 1 (Reuters) - Mylan Nv: \n* MYLAN EXPANDS ACCESS TO HIV/AIDS MEDICINES WITH LAUNCH OF FIRST GENERIC SUSTIVA® TABLETS \n* MYLAN - ANNOUNCED U.S. LAUNCH OF EFAVIRENZ TABLETS USP, 600 MG, FIRST GENERIC VERSION OF BRISTOL-MYERS’ SUSTIVA \n* MYLAN NV - CO ELIGIBLE FOR 180 DAYS OF GENERIC DRUG EXCLUSIVITY IN RELATION TO GENERIC SUSTIVA TABLETS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-01T14:35:00.000+02:00", "crawled": "2018-02-01T14:44:42.018+02:00", "highlightTitle": ""}